<DOC>
	<DOCNO>NCT00705666</DOCNO>
	<brief_summary>In February 2002 , French Consensus Conference management patient chronic hepatitis C France organize . The jury issue several recommendation pegylated alpha interferon/ribavirin treatment strategy . Three year recommendation , interest understand evolution hepatitis C management France real clinical practice . This observational study permit identification patient treat provide information use PegIntron/ Ribavirin .</brief_summary>
	<brief_title>Treatment Patients With Chronic Hepatitis C With PegIntron Monotherapy Combination With Ribavirin ( Study P04437 ) ( COMPLETED )</brief_title>
	<detailed_description>To assure good representation participant treat hepatitis C , participant meet inclusion criterion enrol consecutive basis .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Adult participant start treatment PegIntron treatment chronic hepatitis C. Concomitant participation clinical trial treatment hepatitis C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>